Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.

Abstract

APS is among the variables that confer decreased survival on patients with SLE. This decreased survival is due to some (e.g., thrombocytopenia or arterial occlusions), but not all, of the manifestations of APS.